COVID-19 and asthma: To have or not to have T2 inflammation makes a difference? - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Pediatric Pulmonology Année : 2020

COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?

Résumé

During this pandemic, there has been some data discrepancy about whether patients with asthma have a lower risk of becoming infected or seriously ill from coronavirus disease 2019 (COVID-19)1 but there is no information about the real impact of SARS-CoronaVirus-2 (SARS-CoV-2) on asthma control. Recent reports from the United States of America suggest that asthma is more common in children and adults with mild to severe COVID-19 than was previously reported in Asia and in Europe, but the prevalence is no higher than that described in the same population.

Dates et versions

hal-03594580 , version 1 (02-03-2022)

Identifiants

Citer

M. Morais-Almeida, J. Bousquet. COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?. Pediatric Pulmonology, 2020, 26 (5), pp.261-263. ⟨10.1016/j.pulmoe.2020.05.003⟩. ⟨hal-03594580⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More